Diberdayakan oleh Blogger.

Popular Posts Today

Morgan Stanley sells Aurobindo Pharma shares worth Rs 116cr

Written By Unknown on Sabtu, 31 Mei 2014 | 08.11

Morgan Stanley Asia Singapore, which is a shareholder of Aurobindo Pharma, sold 17,32,500 shares of the drug company for about Rs 670 apiece, valuing the transaction at Rs 116 crore.

Foreign fund house Morgan Stanley Asia Singapore today offloaded 17.32 lakh shares of  Aurobindo Pharma for Rs 116 crore through an open market transaction.

In a separate transaction, Abu Dhabi Investment Authority picked up 14.75 lakh shares of the pharmaceutical firm for an estimated amount of nearly Rs 99 crore, bulk deal details with the stock exchanges showed.

Morgan Stanley Asia Singapore, which is a shareholder of Aurobindo Pharma, sold 17,32,500 shares of the drug company for about Rs 670 apiece, valuing the transaction at Rs 116 crore.

Morgan Stanley Asia Singapore held 46.16 lakh shares of Aurobindo Pharma representing 1.58 percent stake in the company as on March 31, 2014.

Aurobindo Pharma has been included in the MSCI Global Standard Indices from today. Shares of Aurobindo Pharma rose 4.76 percent to end the day at Rs 667.70 apiece on the BSE.

Aurobindo Pharm stock price

On May 30, 2014, Aurobindo Pharma closed at Rs 667.70, up Rs 30.35, or 4.76 percent. The 52-week high of the share was Rs 678.40 and the 52-week low was Rs 138.45.


The company's trailing 12-month (TTM) EPS was at Rs 31.05 per share as per the quarter ended December 2013. The stock's price-to-earnings (P/E) ratio was 21.5. The latest book value of the company is Rs 100.84 per share. At current value, the price-to-book value of the company is 6.62.


08.11 | 0 komentar | Read More

World's largest aircraft the Airbus A380 landed at IGIA

Super jumbo Airbus A380 of the Singapore Airlines (SIA) landed at the Indira Gandhi International Airport (IGIA) in New Delhi at around 8.00 pm on Friday, marking its maiden flight to India. On its arrival, the super jumbo was given a customary water cannon salute.

Singapore Airlines became the first airline to start commercial operations of the world's largest passenger aircraft Airbus 380 in India on Friday. The airline will fly daily from Mumbai and Delhi.

The world's largest passenger aircraft will have 471 seats, including 12 suites, 60 Business and 399 Economy class seats.

An Economy class ticket for the Airbus will set you back by Rs 30,000, the Business class ticket will cost twice more and the suites will be priced at Rs 2 lakh each. Extra-long baggage belts have been made to clear the 1000 bags expected on each flight.

The first flight comes after the government in January 2014 allowed Airbus A380 to fly into the country.

The civil aviation ministry had lifted the ban imposed in 2008 on the ground that operation of A380s could work against the interest of Indian passenger carriers.

The Delhi airport was purpose built for the A380. A 4.43 km long and 75 metre wide runway was built, a matching network comprising kilometers of taxiways and acres of apron to support the weight of the 560 tonne aircraft has also been made.

At present only four airports - Delhi, Mumbai, Hyderabad and Bangalore - have the required infrastructure for handling A380 operations.

Meanwhile, Gulf carrier Emirates on Wednesday also announced the launch of its A380 operations between Mumbai and Dubai from July 21 adding a capacity of 2,127 seats per week in each direction.

It will be the second global carrier after Singapore Airlines to start its super jumbo services. Emirates would launch daily services of the double-decker Airbus A380 aircraft between Dubai and Mumbai, a spokesperson for the Gulf carrier said.

The Airbus A380 features:

- Double

- Engines: 4

- Range: 15,700 kilometre

- Seating: 525 people in a typical three class configuration

- First flight: 27 April 2005

- First commercial service: October 2007 with Singapore Airlines


08.11 | 0 komentar | Read More

Nissan to launch Datsun Go Plus in H2FY15

Written By Unknown on Jumat, 30 Mei 2014 | 08.11

Takashi Hata, Senior Vice President gives the roadmap for his company's plans in India.

Nissan India's miniscule market share in the country has not impressed Takashi Hata, Senior Vice President, Nissan Motors who contends that the Japanese automaker is severely lagging behind.

In a chat with CNBC-TV18's Farah Bookwala Vhora, Hata explains what will bolster Nissan's presence and the company's roadmap for this fiscal.

Below is the transcript of his interview.

Q: What are your plans for India?

Hata: We are humbly accepting the fact that Nissan is underperforming in this very important market.

So we tried to do many things new. We decided to setup new structure of the sales network and we tried to launch the new brand which is Datsun selectively and the new product which is well accepted.

Q: Tell us a little bit more about what the pipeline is going to look like for FY15?

Hata: For Nissan brand the immediate launch is Sunny and the Evalia is on schedule. Also in Datsun brand, we are now scheduling to launch Datsun Go Plus which is another new product. It is coming in later half of this fiscal year.


08.11 | 0 komentar | Read More

Godrej Cons sees demand momentum picking up only after Q3

In an exclusive chat with CNBC-TV18's Farah Bookwala Vhora, Godrej Consumer's MD, Vivek Gambhir explains what will continue to pin down the sector and the future course of action for GCPL.

The Lok Sabha elections may have helped revived economic sentiment to a great extent, but a revival in India's USD 1.5 billion FMCG sector is still away. In an exclusive chat with CNBC-TV18's Farah Bookwala Vhora, Godrej Consumer 's MD, Vivek Gambhir explains what will continue to pin down the sector and the future course of action for GCPL.

"It will take some time before you start seeing this reflected in FMCG. The reason for that is we saw a very significant slowdown in FMCG last year particularly in Q3 and Q4.

Growth with return back. Typically, FMCG tends to be the sector, which gets impacted the last when there is a slowdown. As the economy turns back, you will see a movement happening upwards. But you need to see economic growth first," he told the channel.

Below is a verbatim transcript of the interview

Q: When do you see the revival happening in the sector?

A: It is going to be quite difficult for Q1 and Q2. For the first two quarters, our expectation is that we will continue to see the same kinds of challenges we saw in Q3 and Q4. So, for the first six months of this year the situation will still remain quite tough, though I am optimistic that in Q3 and Q4 you will also see a lot more momentum that starts getting picked up.

Q: Your future strategy would be led by not just deeper penetration but also through brand extensions a combination of both?

A: Strategy in rural India is going to be drive penetration through very disruptive innovations. In urban India largely mosquito repellents and household insecticides have typically been used in the evenings. So, the opportunity now becomes all day usage both in homes and out of home and that\'s how you will start seeing a huge amount of consumption being driven in urban India. So, across categories companies will have to figure out both penetration opportunities and consumption opportunities.

Q: At what point do you see these categories becoming saturated?

A: The strategy is to focus on the core, but over time the definition of core will continue to expand. Our strategy is to continue finding adjacent categories around the core, which might be small today but which will represent future growth platforms.

Godrej Consumer stock price

On May 29, 2014, Godrej Consumer Products closed at Rs 761.75, up Rs 0.45, or 0.06 percent. The 52-week high of the share was Rs 977.40 and the 52-week low was Rs 672.00.


The company's trailing 12-month (TTM) EPS was at Rs 16.59 per share as per the quarter ended March 2014. The stock's price-to-earnings (P/E) ratio was 45.92. The latest book value of the company is Rs 97.71 per share. At current value, the price-to-book value of the company is 7.80.


08.11 | 0 komentar | Read More

Modi effect: Expect eco turnaround in 6 months, says DLF

Written By Unknown on Selasa, 27 Mei 2014 | 08.11

He is certain the ex-Gujarat CM will introduce REITs and FIIs will once again give India "a serious look" now.

Narendra Modi knows exactly what to do and how to do it. That's the belief of Rajiv Singh of  DLF who is confident that the realty sector will get a booster under the Modi-led government. He is certain the ex-Gujarat CM will introduce REITs and FIIs will once again give India "a serious look" now.

"It will take approximately six-months for an economic turnaround," he told CNBC-TV18 in an interview.

Also Read: 57% of Indians think next 30 days good time to buy realty

DLF stock price

On May 26, 2014, DLF closed at Rs 204.35, down Rs 12.2, or 5.63 percent. The 52-week high of the share was Rs 224.55 and the 52-week low was Rs 120.25.


The company's trailing 12-month (TTM) EPS was at Rs 1.43 per share as per the quarter ended December 2013. The stock's price-to-earnings (P/E) ratio was 142.9. The latest book value of the company is Rs 67.20 per share. At current value, the price-to-book value of the company is 3.04.


08.11 | 0 komentar | Read More

Pfizer gives up USD 117bn pursuit of AstraZenaca

Commenting on the development, Pfizer Chairman and CEO Ian Read said: "We continue to believe that our final proposal was compelling and represented full value for AstraZeneca based on the information that was available to us."

US drug major Pfizer today shelved its USD 117-billion takeover bid of AstraZenaca on the day of expiry of the offer as the British pharmaceutical company remained firm in opposing the deal.

"Following the AstraZeneca board's rejection of the proposal, Pfizer announces that it does not intend to make an offer for AstraZeneca," the company said in a statement.

Commenting on the development, Pfizer Chairman and CEO Ian Read said: "We continue to believe that our final proposal was compelling and represented full value for AstraZeneca based on the information that was available to us."

He further said the pursuit of this transaction was a potential enhancement to the company's existing strategy.

On May 18, 2014, Pfizer had announced that it had made a final proposal to AstraZeneca to make an offer to combine the two companies.

The US firm had urged "supportive AstraZeneca shareholders to urge the AstraZeneca board to begin substantive engagement with Pfizer and extend the period for such talks prior to the May 26 deadline for making an offer".

Pfizer Inc, the New York-based maker of lockbuster drugs such as Lipitor and Viagra, had made a final offer of 55 pounds a share to Astrazeneca on May 18, which was 15 per cent higher than its last bid made on May 2.

Reacting to the final proposal, AstraZeneca had said it undervalued the company and "its attractive prospects and has been rejected by the board of AstraZeneca".

Pfizer had earlier approached AstraZeneca on January 5 and April 26 with a proposal to acquire the company for USD 100 billion. On May 2, the company had raised the offer to USD 106 billion.

Under the final proposal, Pfizer and AstraZeneca shareholders would have owned approximately 74 per cent and 26 per cent, respectively, of the combined company.

AstraZeneca's products include drugs to treat cancer, gastrointestinal and cardiovascular and metabolic diseases.

AstraZeneca stock price

On February 17, 2014, AstraZeneca Pharma closed at Rs 836.75, up Rs 22.75, or 2.79 percent. The 52-week high of the share was Rs 1240.00 and the 52-week low was Rs 595.00.


The latest book value of the company is Rs 39.90 per share. At current value, the price-to-book value of the company was 20.97.


08.11 | 0 komentar | Read More

AP HC vacates status quo order on Sun Pharma-Ranbaxy merger

Written By Unknown on Senin, 26 Mei 2014 | 08.11

The petitioners alleged that there was heavy trading of Ranbaxy stock before the merger with Sun Pharma was announced on April 6.

The Andhra Pradesh High Court Saturday vacated the status quo order it had issued earlier on the merger process between  Sun Pharma and Ranbaxy .

A petition in this regard was filed by two investors requesting the High Court to restrain the BSE and the NSE from giving any clearance to the scheme of amalgamation or merger between Sun Pharma and Ranbaxy.

The petitioners alleged that there was heavy trading of Ranbaxy stock before the merger with Sun Pharma was announced on April 6.

They requested the court to direct market regulator Sebi to investigate the insider trading of Ranbaxy shares and take appropriate action against Sun Pharma and Silver Street Developers.

The court had earlier issued interim orders to maintain status quo with regard to the merger.

Justice G Chandraiah today vacated the status quo. The Sebi had yesterday informed the court that an investigation is currently going on into the allegations of insider trading.

The bourses are yet to forward their opinion on the merger or amalgamation issue to the market regulator.

The Mumbai-based Sun Pharma had on April 6 announced that it would fully acquire Ranbaxy in an all-stock transaction with a total equity value of USD 3.2 billion, along with debt of USD 800 million, taking the overall deal value to USD 4 billion.

Sun Pharma stock price

On May 23, 2014, Sun Pharmaceutical Industries closed at Rs 584.70, up Rs 4.60, or 0.79 percent. The 52-week high of the share was Rs 653.10 and the 52-week low was Rs 458.00.


The company's trailing 12-month (TTM) EPS was at Rs 0.95 per share as per the quarter ended December 2013. The stock's price-to-earnings (P/E) ratio was 615.47. The latest book value of the company is Rs 41.64 per share. At current value, the price-to-book value of the company is 14.04.


08.11 | 0 komentar | Read More

AP HC lifting ban positive for Sun-Ranbaxy merger

"The good news is that the merger has been approved and now it will go ahead and therefore, the shareholders, the creditors and the institutions will all stand to gain as a result of the merger going ahead," says HP Ranina.

Sebi's investigation is unlikely to affect the merger given it will find issues involved in insider trading, which is a completely independent action and has nothing to do with the merger

HP Ranina

Corporate Tax Lawyer

After Andhra Pradesh high court  vacates the stay and status quo on the proposed USD 4 billion Sun Pharma - Ranbaxy merger on Saturday, experts believe it is a positive step and will bring in some relief for the two pharma companies.

However, the court has directed market regulator Securities and Exchange Board of India (Sebi) to probe charges of insider trading that led to the stay on the merger.

Corporate lawyer HP Ranina believes Sebi's investigation is unlikely to affect the merger given it will find issues involved in insider trading, which is a completely independent action and has nothing to do with the merger.  Merger is when two companies merge, the assets and liabilities are taken over by the amalgamation company but this has nothing to do with that.

According to Ranina, if somebody made a profit by getting information in advance about the merger and therefore, it had a windfall profit, that person will be in trouble and will be slapped with a penalty and perhaps people involved in the insider trading maybe suspended and may not be allowed to operate in the market, but that's a completely different issue altogether.

"The good news is that the merger has been approved and now it will go ahead and therefore, the shareholders, the creditors and the institutions will all stand to gain as a result of the merger going ahead," he says during a discussion on CNBC-TV18 .

Ranjit Kapadia of Centrum Broking adds to this positive sentiment saying, "There is slightly positive sentiment because now the merger process will initiate and it will give some relief to both the companies, because there was uncertainty in the market that how long the merger will hold because of the Andhra Pradesh High Court issue."

However, Vivek Reddy, advocate says, "In this particular case, one of the parties involved in the insider trading is Silver Street, which is a 100 percent subsidiary of Sun Pharma and so, a party to the merger is also a party to the insider trading and therefore, Sebi was asked to investigate into the matter and punish the wrong doer and prohibit them from accessing the market and getting a merger approved.

But Kapadia contradicts by saying the Sebi investigation will only affect Silver Street, because the main accuse of insider trading is Silver Street Investment."

"The merger swap ratio has been approved by the auditors, creditors, shareholders which is a separate issue but certainly the subsidiary company which has been involved in insider trading could be slapped with a hasty penalty so that whatever profits it has made could be recovered by way of penalty by Sebi and may also be suspended for a certain period of time from operating or accessing the market," adds Ranina.

Sun Pharma stock price

On May 23, 2014, Sun Pharmaceutical Industries closed at Rs 584.70, up Rs 4.60, or 0.79 percent. The 52-week high of the share was Rs 653.10 and the 52-week low was Rs 458.00.


The company's trailing 12-month (TTM) EPS was at Rs 0.95 per share as per the quarter ended December 2013. The stock's price-to-earnings (P/E) ratio was 615.47. The latest book value of the company is Rs 41.64 per share. At current value, the price-to-book value of the company is 14.04.


08.11 | 0 komentar | Read More

AP HC vacates status quo order on Sun Pharma-Ranbaxy merger

Written By Unknown on Minggu, 25 Mei 2014 | 08.11

The petitioners alleged that there was heavy trading of Ranbaxy stock before the merger with Sun Pharma was announced on April 6.

The Andhra Pradesh High Court Saturday vacated the status quo order it had issued earlier on the merger process between  Sun Pharma and Ranbaxy .

A petition in this regard was filed by two investors requesting the High Court to restrain the BSE and the NSE from giving any clearance to the scheme of amalgamation or merger between Sun Pharma and Ranbaxy.

The petitioners alleged that there was heavy trading of Ranbaxy stock before the merger with Sun Pharma was announced on April 6.

They requested the court to direct market regulator Sebi to investigate the insider trading of Ranbaxy shares and take appropriate action against Sun Pharma and Silver Street Developers.

The court had earlier issued interim orders to maintain status quo with regard to the merger.

Justice G Chandraiah today vacated the status quo. The Sebi had yesterday informed the court that an investigation is currently going on into the allegations of insider trading.

The bourses are yet to forward their opinion on the merger or amalgamation issue to the market regulator.

The Mumbai-based Sun Pharma had on April 6 announced that it would fully acquire Ranbaxy in an all-stock transaction with a total equity value of USD 3.2 billion, along with debt of USD 800 million, taking the overall deal value to USD 4 billion.

Sun Pharma stock price

On May 23, 2014, Sun Pharmaceutical Industries closed at Rs 584.70, up Rs 4.60, or 0.79 percent. The 52-week high of the share was Rs 653.10 and the 52-week low was Rs 458.00.


The company's trailing 12-month (TTM) EPS was at Rs 0.95 per share as per the quarter ended December 2013. The stock's price-to-earnings (P/E) ratio was 615.47. The latest book value of the company is Rs 41.64 per share. At current value, the price-to-book value of the company is 14.04.


08.11 | 0 komentar | Read More

AP HC lifting ban positive for Sun-Ranbaxy merger

"The good news is that the merger has been approved and now it will go ahead and therefore, the shareholders, the creditors and the institutions will all stand to gain as a result of the merger going ahead," says HP Ranina.

Sebi's investigation is unlikely to affect the merger given it will find issues involved in insider trading, which is a completely independent action and has nothing to do with the merger

HP Ranina

Corporate Tax Lawyer

After Andhra Pradesh high court  vacates the stay and status quo on the proposed USD 4 billion Sun Pharma - Ranbaxy merger on Saturday, experts believe it is a positive step and will bring in some relief for the two pharma companies.

However, the court has directed market regulator Securities and Exchange Board of India (Sebi) to probe charges of insider trading that led to the stay on the merger.

Corporate lawyer HP Ranina believes Sebi's investigation is unlikely to affect the merger given it will find issues involved in insider trading, which is a completely independent action and has nothing to do with the merger.  Merger is when two companies merge, the assets and liabilities are taken over by the amalgamation company but this has nothing to do with that.

According to Ranina, if somebody made a profit by getting information in advance about the merger and therefore, it had a windfall profit, that person will be in trouble and will be slapped with a penalty and perhaps people involved in the insider trading maybe suspended and may not be allowed to operate in the market, but that's a completely different issue altogether.

"The good news is that the merger has been approved and now it will go ahead and therefore, the shareholders, the creditors and the institutions will all stand to gain as a result of the merger going ahead," he says during a discussion on CNBC-TV18 .

Ranjit Kapadia of Centrum Broking adds to this positive sentiment saying, "There is slightly positive sentiment because now the merger process will initiate and it will give some relief to both the companies, because there was uncertainty in the market that how long the merger will hold because of the Andhra Pradesh High Court issue."

However, Vivek Reddy, advocate says, "In this particular case, one of the parties involved in the insider trading is Silver Street, which is a 100 percent subsidiary of Sun Pharma and so, a party to the merger is also a party to the insider trading and therefore, Sebi was asked to investigate into the matter and punish the wrong doer and prohibit them from accessing the market and getting a merger approved.

But Kapadia contradicts by saying the Sebi investigation will only affect Silver Street, because the main accuse of insider trading is Silver Street Investment."

"The merger swap ratio has been approved by the auditors, creditors, shareholders which is a separate issue but certainly the subsidiary company which has been involved in insider trading could be slapped with a hasty penalty so that whatever profits it has made could be recovered by way of penalty by Sebi and may also be suspended for a certain period of time from operating or accessing the market," adds Ranina.

Sun Pharma stock price

On May 23, 2014, Sun Pharmaceutical Industries closed at Rs 584.70, up Rs 4.60, or 0.79 percent. The 52-week high of the share was Rs 653.10 and the 52-week low was Rs 458.00.


The company's trailing 12-month (TTM) EPS was at Rs 0.95 per share as per the quarter ended December 2013. The stock's price-to-earnings (P/E) ratio was 615.47. The latest book value of the company is Rs 41.64 per share. At current value, the price-to-book value of the company is 14.04.


08.11 | 0 komentar | Read More

NSEL begins remittance of payout to unit-holders of E-Gold

Written By Unknown on Sabtu, 24 Mei 2014 | 08.11

NSEL had a total of 617.5 kgs of gold eligible for rematerialisation and financial closure. Pursuant to FMC issuing the NOC, the exchange had issued the circular on April 4 for rematerialisation/financial closure of e-series settlement.

As a part of the financial closure of gold e-series contracts, National Spot Exchange Ltd (NSEL) today started making direct payments to over 21,000 unit-holders at the average rate of Rs 2,935.9925 per gram.

NSEL had a total of 617.5 kgs of gold eligible for rematerialisation and financial closure. Pursuant to FMC issuing the NOC, the exchange had issued the circular on April 4 for rematerialisation/financial closure of e-series settlement.

NSEL went into trouble in July last year after two dozen counterparties declared their inability to settle payments amounting to Rs 5,600 crore to more than 13,000 investors. A total of 85.5 kgs of gold were released to the unit holders in the rematerialisation process.

Also read:  Court extends police custody of Jignesh Shah, Javalgekar

The remaining 532 Kgs of gold that were held by NSEL on behalf of unit holders were taken up for financial closure starting May 8. Of this, 477 kgs of gold was sold through auction which is 89.70 percent of the stock available for financial closure, a statement issued here said.

All eligible unit-holders of E-Gold will get remittance to the tune of 89.70 percent against their each unit of holding, while the remittance for their remaining 10.30 percent will be given once NSEL auctions the remaining stock.

For other metals, the auction is in progress and the direct payout will be released to eligible unit holders as per the circular issued by NSEL. NSEL had suspended the paired contracts but continued settlement of the e-series contracts.

However, the settlement to e-series investors also was put on hold after two investors, who moved the Bombay High Court, alleged that money invested into paired contracts was used to purchase metal backing the e-series contracts. The High Court in October last year suspended the settlement of the e-series and directed commodity market Forward Markets Commission to appoint a chartered accountancy firm to conduct a forensic audit of the contracts.


08.11 | 0 komentar | Read More

Caledonia sells 3 % stake in Dewan Housing for Rs 114 cr

As on quarter-ended March 2014, Caledonia Investments held 1.28 crore shares of Dewan Housing Finance amounting to 9.98 percent stake in the company.

UK-based Caledonia Investments today offloaded nearly 3 percent of its stake in mortage lender  Dewan Housing Finance Corporation Ltd for an estimated Rs 114 crore through the open market route.

The investment trust sold 38 lakh shares (representing about 3 percent stake) of the mortgage lender at average price of Rs 300 apiece, as per bulk deal details with the BSE. In a separate transaction, foreign fund house Morgan Stanley Asia Singapore acquired 37.78 lakh shares of Dewan Housing Finance in a transaction worth Rs 113.35 crore.

As on quarter-ended March 2014, Caledonia Investments held 1.28 crore shares of Dewan Housing Finance amounting to 9.98 percent stake in the company. For the same period, Morgan Stanley Asia Singapore held 15.11 lakh shares of the mortage lender representing a shareholding of 1.18 percent.

Dewan Housing Finance was established to enable access to affordable housing finance to the lower and middle income groups in semi-urban and rural parts of India. Shares of Dewan Housing today rose 3.94 percent to settle the day at Rs 334.75 apiece on the BSE.

Dewan Housing stock price

On March 20, 2014, Dewan Housing Finance Corporation closed at Rs 206.50, up Rs 1.05, or 0.51 percent. The 52-week high of the share was Rs 242.65 and the 52-week low was Rs 101.50.


The company's trailing 12-month (TTM) EPS was at Rs 41.17 per share as per the quarter ended March 2014. The stock's price-to-earnings (P/E) ratio was 5.02. The latest book value of the company is Rs 293.12 per share. At current value, the price-to-book value of the company is 0.70.


08.11 | 0 komentar | Read More

Vodafone India may overtake UK by revenues in few years

Written By Unknown on Jumat, 23 Mei 2014 | 08.11

Led by strong growth in service revenue and accelerated data performance, Vodafone India is all set to overtake UK to become the top contributor to the Group's revenues in next few years.

"We are the fastest growing in the Vodafone Group now. we grew 13 percent (in local currency) this year," Vodafone India Managing Director & CEO Marten Pieters said.

Asked how long it will take to overtake UK, Pieters said it can be done in the next few years.

"We already had overtaken them until they bought Cable and Wireless, which had a considerable revenue in the UK but we are actually very close again...we can overtake in the next few years," he added.

India is a key strategic growth market for Vodafone Group and the local unit is third largest contributor to Group service revenues (after UK and Germany) and third largest contributor to Group operating free cash flows (after Germany and SA).

Also read:  Will focus on IPO after next spectrum auction: Vodafone CEO

A 100 percent subsidiary of the Group, Vodafone India is also fifth largest contributor to Group EBITDA (after Germany, Italy, SA and UK).

The company had reported a first time net profit in India since its entry in 2007 mainly on the back of growth in data and increased call charges.

Vodafone India had a 125 percent year-on-year increase in data traffic. Vodafone had 52 million data customers in India, with 7 million of them 3G data customers.

The country's second-largest operator has reported a 25.9 percent jump in EBITDA (earnings before interest, taxes, depreciation and amortisation) to Rs 13,398.6 crore for FY'14, compared with Rs 10,640.6 crore in FY'13.

The company's service revenue rose 13 percent to Rs 37,606 crore for the financial year from Rs 33,281.8 crore previously.

As part of the Project Spring, Vodafone will make organic investments of about GBP 19 billion across geographies over the next two years.

The main elements of the Project Spring investment programme include 4G in Europe, where it aims to reach 91 percent population coverage by 2016, and 3G in emerging markets, especially India, where it plans to cover 95 percent of the population by 2016.


08.11 | 0 komentar | Read More

SpiceJet may to sell some overseas slots to Qatar Airways

Sources said Qatar Airways has evinced interest in buying some of the SpiceJet's overseas slots as part of its strategy to enter the country's aviation market.

Gulf carrier Qatar Airways is likely to invest in the debt-ridden SpiceJe t by purchasing its parking slots overseas, sources said.

Officials of the state-run Qatar Investment Promotion Authority are likely to meet the top brass of SpiceJet shortly, they added.

The Kalanithi Maran-promoted domestic airline had earlier this week said it was in " advanced stage of discussions" with an overseas entity for capital infusion . "A team of officials from Qatar Investment Promotion Authority is scheduled to meet the SpiceJet management in a day or two to discuss investment plans of Qatar Airlines," a source told PTI.

Sources further said Qatar Airways has evinced interest in buying some of the SpiceJet's overseas slots as part of its strategy to enter the country's aviation market. "Considering that another Gulf carrier Etihad, which has acquired 24 percent equity in Jet Airways , had also bought Jet's three prime slots at London's Heathrow Airport for USD 70 million prior to the signing of the deal, such a transaction is possible," the source added.

When contacted, an SpiceJet spokesperson said: "We do not comment on market speculation." The development could not be independently verified with Qatar Airways. "We are in advanced stages of capital infusion discussions with an external entity that when completed will help us clean up our arrears and rebuild with confidence," the airline had said in a statement earlier.

The airline had reported its worst-ever financial numbers in the just-concluded FY 2014-- a record net loss of Rs 1,003 crore.

SpiceJet stock price

On May 16, 2014, SpiceJet closed at Rs 15.05, down Rs 0.1, or 0.66 percent. The 52-week high of the share was Rs 40.90 and the 52-week low was Rs 12.50.


The latest book value of the company is Rs -22.24 per share. At current value, the price-to-book value of the company was -0.68.


08.11 | 0 komentar | Read More

Mukesh Ambani keeps salary capped at Rs 15cr for 6th year

Written By Unknown on Kamis, 22 Mei 2014 | 08.11

Reliance Industries  Chairman Mukesh Ambani kept his annual salary capped at Rs 15 crore for the sixth year in a row even as the remuneration of key executives went up.

Ambani, the richest Indian, has kept salary, perquisites and allowances and commission at Rs 15 crore since 2008-09, foregoing almost Rs 24 crore per annum.

"The Chairman and Managing Director's compensation has been set at Rs 15 crore as against Rs 38.86 crore as per shareholders' approval, reflecting his desire to continue to set a personal example for moderation in managerial compensation levels," RIL said in its annual report for the financial year ended March 31, 2014.

His remuneration for 2013-14 included Rs 4.16 crore as salary, perquisites and allowances of Rs 60 lakh, retirement benefits of Rs 82 lakh and Rs 9.42 crore as commission on profit.

In the previous year, while his salary and perquisites and allowances were the same, he got commission of Rs 9.35 crore and Rs 89 lakh in retirement benefits.

Ambani voluntarily capped his compensation at Rs 15 crore in October 2009 amid a debate over right-sizing of CEO salaries.

While Ambani's salary remained capped, his key executives including oil and gas head P M S Prasad and refinery chief Pawan Kumar Kapil saw increases in compensation.

Prasad's annual package went up to Rs 6.03 crore from Rs 5.47 crore in 2012-13 after getting a higher performance-linked incentive of Rs 3.67 crore (Rs 3.12 crore the previous year).

Kapil earned Rs 1.05 crore performance-linked incentive to take his total package to Rs 2.49 crore in 2013-14. In the previous year, he earned Rs 1.99 crore, including Rs 65 lakh performance-linked incentive.

The criteria and the entitlement for performance-linked incentives for the two executives are determined by the Human Resources, Nomination and Remuneration Committee, RIL said.

Ambani's cousins Nikhil R Meswani and Hital R Meswani saw their compensation rise to Rs 12.12 crore from Rs 11.05 crore a year ago. RIL's non-executive directors also got Rs 50 lakh each as commission, besides sitting fees ranging from Rs 1 lakh to 4 lakh.

Apart from Ambani, the RIL board has the Meswani brothers, Prasad, Kapil and company founder Dhirubhai Ambani's brother Ramniklal H Ambani. Its independent directors include Dharam Vir Kapur, Dipak C Jain, Mansingh L Bhakta, Yogendra P Trivedi, Mahesh P Modi, Ashok Misra, Raghunath A Mashelkar and Adil Zainulbhai.

Reliance stock price

On May 21, 2014, Reliance Industries closed at Rs 1078.10, down Rs 0.4, or 0.04 percent. The 52-week high of the share was Rs 1142.50 and the 52-week low was Rs 765.00.


The company's trailing 12-month (TTM) EPS was at Rs 68.01 per share as per the quarter ended March 2014. The stock's price-to-earnings (P/E) ratio was 15.85. The latest book value of the company is Rs 556.88 per share. At current value, the price-to-book value of the company is 1.94.


08.11 | 0 komentar | Read More

Expect advertising revenues to grow 11-12% this year: Zee

Several analysts have held out hope that with the ongoing digitization in the country, media stocks are poised for a major bull run in the next few years.

But in the face of a weak economy, revenue growth at least for now has been sluggish.

In an interview with  Zee Entertainment Enterprises MD and CEO Punit Geonka, CNBC-TV18's Shereen Bhan discussed the company's growth prospects over the medium term and challenges that the industry as a whole faces.

Goenka said that even as the first two phases of digitization was complete, the complete benefits were yet to trickle down to the entire media spectrum, and especially to the multiple system operators (MSOs) and local cable operators (LCOs).

Goenka also discussed the closure of the distribution joint venture that Zee had started with Star.

Below is the edited transcript of the interview on CNBC-TV18.

Q: 2013 was a difficult year for the industry. We saw regulatory changes, weak advertising environment and slow economic growth which sort of curtailed the kind of numbers that we would have liked to see as far as our business is concerned. The hope and the assumption is that in 2014, acche din aayenge. Does that look like it is going to bear out?

A: I am an optimist. I think things will improve. There is no way to go but up from here. The industry has had its issues in the last one year but definitely things will go in the right direction.

Q: What is the big hope for you? Is digitization the big hope because we are done with phase I and phase II. There are still question marks on whether you have fully be able to juice out what phase I and phase II has offered or whether you are going to see the results of this over the next two years or so. First let me get your comments on that, the full monetization of the first two phases.

A: According to me, phase I and phase II are also not done because while broadcasters may have been able to get some of the value of digitization for themselves but the entire value chain is still suffering because the last mile billing is still not taking place.

Hence the MSOs are further bleeding in this business. Until the entire value chain doesn't make money it is not in the interest for even broadcasters in the long term. My view is that digitization, even phase I, phase II have to be fully completed over the period of lets say next three-six months where enforcement of the law has to happen now.

Post which phase III, phase IV kick in, let's say during the early part of next year and that will take its own time because logistically to cover that kind of ground will have its own challenges.

So, over the next couple of years we do expect digitization to further play out.

Q: When do you actually see at least as far as value accretion on account of phase i and phase ii to start kicking in?

A: From a broadcaster perspective a lot of it has already come in. It is the distribution entities that have not seen that coming in for themselves. So, over the next six months, if we can fix that issue, the MSO business becomes healthy, the LCOs also can have a good, robust enough business model.

Q: What is coming in the way at this point in time of that happening?

A: It is the sheer will of the distribution channels or the fear that they may lose subscribers to competition such as DTH that one is facing.

However, if the industry can come together, the MSOs and the DTH industry can work together to say that the pie is large enough for all of us to make enough money here rather than trying to eat into each others markets, this business can be fixed.

Q: There has been a lot of talk and lot of discussion on the splitting up [of MediaPro, the joint venture distribution business of Star and Zee]. How does life change now for you? There has been a fair degree of concern on what this is actually going to mean as far as Zee is concerned. Analysts believe that the impact is going to be largely limited on your business. What is your own assessment and what do we expect now from here on for you?

A: Let's rewind back to first before the joint venture was formed and the reasons for the JV being created. The two primary reasons for the JV coming together was that both of us in the analog business were not getting the kind of growth that we wanted.

Both were struggling with single digits, mid-single-digit numbers 5 and 6 percent for each other. Digitization was not really getting pushed as competition would have…

Q (Interrupts): So it was necessity that brought you and STAR together?

A: Absolutely and today when the rules have been set, each of us has found the prize point that we are going to operate at. We have demonstrated that not just in DTH but even in cable at least in phase 1 and phase 2, the true benefits of MediaPro have already been derived.

Now going forward, given the regulation; given that we need to consolidate within our own organization by which I mean the sport businesses needs to get consolidated, we just felt that it has lived its purpose and now we both should go on our way.

Q: So, it was a marriage of convenience. Did irreconcilable differences finally lead to the two of you splitting apart?

A: I don't think so. We had our differences in the first year of operations and as far as I can remember there was not a single issue that we couldn't resolve within 15 minutes. We never had to negotiate, we never had to go fight with each other and the joint venture (JV) was there for three years. Regulation timed itself pretty well for us to complete the three years before we had to call it off.

Q: From a market perspective, the question is that is this going to hit you and your profitability in any form or fashion.

A: I don't think it will hit our profitability in any way. There will be opportunists in the market who will try and take advantage of this separation and that may cause some issues in for a quarter or two where our contracts don't get done and there are delays but eventually my value is what I deliver and therefore I will demand that and get that.

Q: So this process of contract renegotiation, there is a lot of buzz around it on how much you are going to be able to make this process at this point in time, how much leverage you enjoy. What can we expect and how much of an upside do you believe there is to renegotiate contracts today?

A: I had said even before the decision of MediaPro going away [was taken] that this year is going to be a slow year for subscription given that we have seen the kind of growth in the last three years and that phase III and phase IV has definitely got delayed with phase I and phase II having its own problems that we just talked about.

However, if you look at the track record, a healthy teen number -- 15-16 percent growth rate over the next two-three years is definitely doable in subscription.

Q: What about advertising because there is hope in general that there is expected to be a pick-up as far as the economy is concerned. You have actually outperformed the industry when it comes to advertising revenues. Do you anticipate strong double-digit growth as far as advertising revenues are concerned?

A: It will take time. I don't think it is an overnight thing that people are expecting the economy to turn just because the elections got over and people are excited about it.

Q: Obviously not. But, the sense is as you pointed out it can only get better from here on.

A: Maybe not in the immediate year for [advertising revenue to grow in] the healthy teens but definitely going forward it should come back. This year I will still be cautious and say I see 11-12 percent kind of growth levels.

Q: For the industry or for you?

A: I will always try and beat the industry.

Q: That's what I am saying so should we expect what a 20 percent kind of growth rate as far as advertising revenues, you have done that in the past.

A: I have so I should just restrain myself and say I will try and beat the industry as I have done in the past -- by how much, let's see.


08.11 | 0 komentar | Read More

Will focus on IPO after next spectrum auction: Vodafone CEO

Written By Unknown on Rabu, 21 Mei 2014 | 08.11

Turning profitable for the first time after entering the country, Vodafone India said mobile tariffs need to go up as input costs are rising, but smaller operators offering cheaper rates are not making it easy.

We would like to see that the industry is not seen as a milking cow for the government only.

Marten Pieters

CEO

Vodafone India

The historic win by Narendra Modi-led NDA has not only Indians, but also foreign players like Vodafone looking forward to better days ahead. Speaking to CNBC-TV18's Malvika Jain, Vodafone India Managing Director & CEO Marten Pieters said he believes the country is ready for a change. And although investment climate in India has not changed yet, he said, FIIs will be happy to come back if tax stability returns.  

Pieters said companies cannot work if the government changes rules of the game every year. He believes that predictability, continuous regulations are a must to do well in any business. However, he did add that the regulatory environment in the country has stabilised, although some issues need to be resolved. "India's tax situation has been aggressive over the last few years," he told the channel.

Also Read: Vodafone India FY14 adjusted operating profit at Rs 3,496cr

Vodafone got a favourable ruling from the Supreme Court on the Rs 11,000-crore tax demand made by the Indian government, but the case was quickly reopened by the government by way of a retrospective amendment in the budget.

Pieters said telecos would like to see less money going the government and more towards investments. He said the telecom major has paid the government Rs 64,000 crore over the last five years.

Turning profitable for the first time after entering the country, Vodafone India said mobile tariffs need to go up as input costs are rising, but smaller operators offering cheaper rates are not making it easy. Vodafone believes broadband is the need of the hour, and India needs more spectrum to effectively push the business. "We must work with the government to get access to more specutrum and hike internet penetration," he said.

Commenting on telecos' IPO plans, Pieters said it will bring the issue to front burner once the next spectrum auction is done. Vodafone had postponed its IPO as it did not know the amount to be paid in the auction. "We would like to get the tax case resolved before we do an IPO," Pieters said.

Next page: Full interview transcript


08.11 | 0 komentar | Read More

Sun Pharma's Karkhadi unit gets warning letter from USFDA

The US Food and Drug Administration said there were reasons to suggest a general lack of reliability and accuracy of data, including missing fundamental raw data, unacceptable data handling practice and inadequate investigation into 'the pervasive practice of deleting (raw) files'.

The US health regulator has warned  Sun Pharma it may withhold approval of new drug applications and extend an import ban at its Karkhadi unit in Gujarat if violations of manufacturing norms at the facility are not corrected.

The US Food and Drug Administration said there were reasons to suggest a general lack of reliability and accuracy of data, including missing fundamental raw data, unacceptable data handling practice and inadequate investigation into 'the pervasive practice of deleting (raw) files'.

"Until all corrections have been completed and FDA has confirmed corrections of the violations and deviations and your firm's compliance with CGMP (current good manufacturing practice), FDA may withhold approval of any new applications or supplements listing your firm as a drug product or an API manufacturer," USFDA said.

In addition, failure to correct the violations and deviations may result in FDA continuing to refuse admission of articles manufactured at Karkhadi into the US, it said.

The warning letter was shot off after the USFDA conducted a review of Sun Pharma's initial response to the issues raised during inspection of the facility in November last year. "...it lacks sufficient corrective actions. We also acknowledge receipt of your firm's additional correspondence dated January 28, 2014, and March 11, 2014," the USFDA said.

In March this year, the health regulator had banned the import of drugs from the Karkhadi facility for violation of manufacturing norms. USFDA said its investigators observed specific deviations during the inspection of the API manufacturing facility, including "failure to ensure that laboratory records included complete data derived from all tests necessary to ensure compliance with established specifications and standards."

The health regulator pointed out "failure to assign and identify raw materials with a distinctive code, batch, or receipt number, and to identify the disposition of materials" at the Kharkhadi facility.

Mumbai-based Sun Pharma's Karkhadi facility manufactures antibiotics and active pharmaceutical ingredients (APIs). The company, which is acquiring Ranbaxy Laboratories, has 10 manufacturing sites in India.

Sun Pharma shares closed at Rs 587.30 on the BSE, up 0.63 per cent.

Sun Pharma stock price

On May 20, 2014, Sun Pharmaceutical Industries closed at Rs 587.30, up Rs 3.70, or 0.63 percent. The 52-week high of the share was Rs 653.10 and the 52-week low was Rs 458.00.


The company's trailing 12-month (TTM) EPS was at Rs 0.95 per share as per the quarter ended December 2013. The stock's price-to-earnings (P/E) ratio was 618.21. The latest book value of the company is Rs 41.64 per share. At current value, the price-to-book value of the company is 14.10.


08.11 | 0 komentar | Read More

Tata Power invests Rs 300 cr to strengthen Mumbai network

Written By Unknown on Selasa, 20 Mei 2014 | 08.11

The company laid a total network of 602 km and commissioned six distribution and 85 consumer sub-stations in Mumbai during the year, a Tata Power release said.

Private utility Tata Power  today said it has invested over Rs 300 crore in FY2013-14 to strengthen distribution network in the metropolis.

The company laid a total network of 602 km and commissioned six distribution and 85 consumer sub-stations in Mumbai during the year, a Tata Power release said.

"In line with our network development strategy, we plan to further strengthen the backbone infrastructure of the city to cater to our growing consumer base. We plan to set up additional 30 distribution sub-stations of which 17 are to be commissioned in the next five years and the remaining 13 post FY'19," Tata Power Executive Director Ashok Sethi said.

The private power firm has five lakh consumers in Mumbai as on April 30. 

Tata Power stock price

On May 19, 2014, Tata Power Company closed at Rs 97.80, up Rs 7.20, or 7.95 percent. The 52-week high of the share was Rs 98.60 and the 52-week low was Rs 68.25.


The company's trailing 12-month (TTM) EPS was at Rs 3.96 per share as per the quarter ended December 2013. The stock's price-to-earnings (P/E) ratio was 24.7. The latest book value of the company is Rs 52.69 per share. At current value, the price-to-book value of the company is 1.86.


08.11 | 0 komentar | Read More

Emerging India Series: Looking at the pharma sector

CNBC-TV18 takes a look at the Indian SME and midsized companies in an industry that globally ranks third in terms of volume and 14th in terms of revenue – the pharmaceutical sector.

Playing mentor to our SME and midsized company on this episode is Dr. Hasit Joshipura, Senior Vice-president South Asia and MD India of GlaxoSmithKline Pharmaceutical. He discussed the trends in the Indian pharma industry and the role of SMEs.


08.11 | 0 komentar | Read More

Not setting up SPV for raising capital from mkt: SBI

Written By Unknown on Senin, 19 Mei 2014 | 08.11

Under the proposal, a bank could set up an SPV to which it will transfer its real estate assets. The bank then can pay rental or lease to the SPV to create an income stream for the SPV.

Country's largest bank  SBI has said that it is not looking at setting up a special purpose vehicle (SPV) for its real estates, an option being considered by the Finance Ministry as a means of raising capital from markets.

"We are not considering that option of SPV," State Bank of India (SBI) Chairperson Arundhati Bhattacharya said.

The idea of setting up an SPV for raising capital from markets was floated at a meeting of Finance Minister P Chidambaram and heads of public sector banks last week.

Also Read: PSU bank boards reasonably professional, says ex-SBI CMD Pratip

Under the proposal, a bank could set up an SPV to which it will transfer its real estate assets. The bank then can pay rental or lease to the SPV to create an income stream for the SPV.

Based on this income stream, the SPV will raise money from markets.

SBI, however, plans to set up a holding company for the purpose of raising capital.

"It (setting up a holding company including all subsidiaries) is one of the possibilities (for raising capital)....currently, there is no clear view on this," she had said.

The proposal for setting up of a holding company with the government, she said, adding, it requires regulatory clearances.

Last week, Financial Services Secretary G S Sandhu had said various options like ESOPs, SPV model and holding company model were discussed in the meeting of Finance Minister P Chidambaram with heads of PSU banks by which banks could raise funds.

He had said the government could provide capital only up to a limited extent and the remaining funds had to be raised from markets.

SBI stock price

On May 16, 2014, State Bank of India closed at Rs 2416.00, up Rs 136.90, or 6.01 percent. The 52-week high of the share was Rs 2505.10 and the 52-week low was Rs 1452.90.


The company's trailing 12-month (TTM) EPS was at Rs 149.34 per share as per the quarter ended December 2013. The stock's price-to-earnings (P/E) ratio was 16.18. The latest book value of the company is Rs 1325.34 per share. At current value, the price-to-book value of the company is 1.82.


08.11 | 0 komentar | Read More

New govt has opportunity to bring changes in telecom: PwC

"The overall majority provides an opportunity to ring in some new tunes for the flagging telecom industry. Now there is a chance to inject fresh momentum into the sector. There are three areas that the new government will have to take up for consideration in the first 100 days," PwC India telecom leader Mohammad Chowdhury said.

Following the BJP's landslide victory in the Lok Sabha election, global consultancy firm PwC has suggested three key areas in the telecom sector which the new government should look at in the first 100 days in office.

"The overall majority provides an opportunity to ring in some new tunes for the flagging telecom industry. Now there is a chance to inject fresh momentum into the sector. There are three areas that the new government will have to take up for consideration in the first 100 days," PwC India telecom leader Mohammad Chowdhury said.

Also Read: Tech Mahindra's USD revenues ahead of expectation, say Analysts

As the rural penetration of mobile connectivity is well below 50 percent, the Narendra Modi government should take a fresh look at encouraging the industry to put more money into rural network expansion and to use up unutilised USO funds, he said.

Clarification of the merger and acquisition norms will facilitate more deals and fuel more investment, Chowdhury added.

Currency stability will help foreign investors and there is an opportunity now to treat all investors fairly and to show no tolerance to corruption, he added.

Though the domestic telcos lead in analytics and pricing, they lack the ingenuity and achievement when it comes to the innovation that could serve a nation that's still in need of better communication, he said.

India needs a new science and education policy that encourages innovation in the telecom space, besides technology and IT, Chowdhury added.


08.11 | 0 komentar | Read More

Young Turks: Rasilant Technologies

Written By Unknown on Minggu, 18 Mei 2014 | 08.11

Rasilant Technologies is an automation solutions and system integration company. It currently serves only the B2B market.

Rasilant Technologies' radio frequency identification technology finds application in the auto identification and data capture sectors. Their product line includes technology that's been used in the logistic sector to track goods, creating auto parking IDs.


08.11 | 0 komentar | Read More

Young Turks: Its My Life Jeans Co

Aaditya Singhal founded Its My Life Jeans Co in 2012, a bespoken personalized jeans design service for women.

Aaditya Singhal set up Its My Life Jeans Company a bespoke and personalize jeans service for women in Delhi. The team launched imljeans.com in 2013 for customers to place their orders and select their preferred design and style online.

Once the user has zeroed in on a product a stylist arrives at door step for measurements and to guide them with additional detailing.


08.11 | 0 komentar | Read More

After victory, BJP must prepare for the real test

Written By Unknown on Sabtu, 17 Mei 2014 | 08.11

Narendra Modi-led BJP posted a historic win by securing over 272 seats all by itself, boosting NDA over 330. However, the pressure has just increased on the party and on the man himself -- to live up to the expectation of the masses and fulfil their hopes.

What should be the next step, how can he boost growth and what reforms should be brought in? CNBC-TV18 speaks to a diversified panel of guests to get an understanding.

Also Read: Modi: Will work hard for the good of all

Vinayak Chatterjee, Chairman and MD of Feedback Infra, said the first major signal from the new government will be cabinet formation.

Sidharth Birla, President, FICCI, thinks the government needs to bring some ministries under the common thread to ensure smooth working.

Mohandas Pai, Chairman of Manipal Universal, sees a strong cabinet in the Modi-led government. He said that he wouldn't be surprised if Modi includes some technocrats too.

Shobhana Bhartia, Editorial Director, Hindustan Times, thinks Modi will go in for a lot of decentralization of power in the PMO. She said though the party has been able to sweep the Lok Sabha seats, they lack numbers in the Rajya Sabha and for the very reason BJP will have to give certain important portfolios to allies, who may help it in getting legislations passed.

On the probable FM candidate, Bhartia said Arun Jaitely holds a good chance.

Pawan Goenka, Executive Director & President, M&M , expects the new government to restore the virtuous cycle of economic growth. Hopeful of GST getting implemented on an immediate term, he said both DTC, and GST must be reverted to old form.

Sumit Mazumdar, President-Designate, CII, feels selection of right people should be the top-most priority for the new government. He, however, cautions that one should not expect anything major in the first 90 days.

Arvind Panagriya, Professor-Economics, Columbia University, said the new government is very much pro-reforms and would lean heavily on growth. He wants the government to hike capital expenditure to 2 percent of the GDP in the Budget.

Dianne Farrel, Executive Vice President, USIBC, expects the Modi-led government to be successful in teaming with the US as he has been "successful in reaching out to FIIs."

She said FIIs are looking for consistency and transparency from the government and the revival of stuck infra projects can send strong signal to them.

She still believes there's a room for FDI in multi-brand retail.

Sounding bullish on India, Jim O' Neill, Ex-chairman of Goldman Sachs, said nobody had expected this kind of victory. He sees a scope of re-rating if Modi-led government takes reform steps soon.


08.11 | 0 komentar | Read More

Sun Pharma settles Novartis lawsuit over drug Gleevec

Sun Pharmaceuticals announced settlement of a legal dispute with Novartis AG in the US on a generic version of patented leukemia drug Gleevec. This settlement is a positive development as it wards off litigation risks and formalizes Sun's launch plans for generic Gleevec, reports CNBC TV18's Archana Shukla.

Sun Pharmaceuticals announced settlement of a legal dispute with Novartis AG in the US on a generic version of patented leukemia drug Gleevec.

This settlement is a positive development as it wards off litigation risks and formalizes Sun's launch plans for generic Gleevec.

While,  Sun Pharma had earlier plans of an 'at-risk' launch of the generic version in December 2015. But considering Sun has recently coughed up USD 500 million as a settlement for a similar at-risk launch of Protonix, the agreement with Novartis is a breather.

Also Read: Sun Pharma jumps 3%, to launch cancer drug in 2016

So now, according to the settlement, Sun Pharma can launch generic version of Gleevec on Feb. 1, 2016 in the US market. The other terms of the agreement are confidential, Sun Pharma said in a statement on Thursday. Sun Pharma's subsidiary already holds a tentative approval from the US Food and Drug Administration for a generic version of Gleevec.  

Gleevec (chemical name: Imatinib mesylate) is used to treat chronic myeloid leukemia and as per IMS data, had annual sales of about USD 2 billion in the United States.

Sun Pharma is reportedly the first generic filer for this drug which means it is entitled to 6 months of marketing exclusivity post patent expiry. It is expected to enter the market with Sandoz, which is the authorized generic (AG) for this drug. With just three players in the market, analysts anticipate Sun Pharma may be able to garner as much as USD 150-160 million revenues in six months of generic Gleevec sales.  

HSBC Securities Girish Bhakru in a note said, "With this settlement the risk involved in launching the product is removed. Plus settlement only pushes product launch by 2 months from earlier best estimate. We had so far not built gGleevec in FY16 estimates. Assuming 40 percent share and 60 percent price erosion in six months Sun will make USD160mn easy."

After Sun Pharma, other generic filers for Gleevec are Dr Reddy , Intas,  Cadila among Indian generics and Teva, Mylan among MNCs. These players are expected to heat up the competition after the six months exclusive period.

Shasun Pharma stock price

On May 16, 2014, Shasun Pharmaceuticals closed at Rs 149.80, down Rs 7.85, or 4.98 percent. The 52-week high of the share was Rs 168.50 and the 52-week low was Rs 45.60.


The company's trailing 12-month (TTM) EPS was at Rs 6.08 per share as per the quarter ended December 2013. The stock's price-to-earnings (P/E) ratio was 24.64. The latest book value of the company is Rs 50.37 per share. At current value, the price-to-book value of the company is 2.97.


08.11 | 0 komentar | Read More

Govt move to stop gas arbitrary, unfair: Deepak Fertilisers

Written By Unknown on Jumat, 16 Mei 2014 | 08.11

"The order of MOPNG to stop supply of natural gas to the company has been taken without any prior notice and is arbitrary, unfair and discriminatory," Deepak Fertilisers said, adding that it has approached the Delhi High Court for remedial measures.

Deepak Fertilizers  today termed the government's decision to stop gas supply to its plant in Maharashtra as 'arbitrary and unfair' and has sought remedial measures in the Delhi High Court. Following orders of the Ministry of Petroleum and Natural Gas (MOPNG), GAIL (India) and Reliance Industries Ltd (RIL) stopped supplying gas to the plant in Raigad district from 6 am today, Deepak Fertilizers said in a BSE filing.

"The order of MOPNG to stop supply of natural gas to the company has been taken without any prior notice and is arbitrary, unfair and discriminatory," Deepak Fertilisers said, adding that it has approached the Delhi High Court for remedial measures. The oil ministry, acting on a request from the Department of Fertilizers, issued orders on May 13 to immediately halt the supply of 0.5 million standard cubic metres of gas a day to the company.

Also Read: Deepak Fertilisers Q4 net jumps over 3-fold to Rs 91.44 cr

"Department of Fertilizers vide letter dated May 1 has conveyed that maximum retail price for nitrogen phosphorus and potassium (NPK) fertilizers under nutrient-based subsidy (NBS) scheme is free and the manufacturers of NPK can absorb the high cost of ammonia in the MRP, whereas the MRP of urea is fixed and statutorily controlled by the government," the oil ministry said in the order.

The shortage of domestic gas has forced urea manufacturing units to rely on exorbitantly high-priced imported LNG, the cost of which the government has to bear in the form of subsidy. "The Department of Fertilizers has requested that the supply of gas to Deepak Fertilisers, which is exclusively manufacturing NPK fertilizers, should be stopped with immediate effect and the said quantity of domestic gas may be allocated/shifted to urea manufacturing units, which are facing shortfall in supply of domestic gas or using high-priced LNG, preferably to National Fertilizers Ltd," it said.

In early 2012, an Empowered Group of Ministers headed by then Finance Minister Pranab Mukherjee had put on hold a proposal to suspend supply of KG-D6 gas to the plant of Deepak Fertilisers till May 24, 2012. The Department of Fertilizers was asked to calculate the gains made by companies using KG-D6 gas in the manufacture of fertilisers other than urea. The gains made in the manufacture of non-urea fertilizer using cheaper gas were to be recovered from these units. However, the Department of Fertilizers has not formulated the guidelines for the same and gas supplies to non-urea fertilizer plants continued for almost two years beyond the stipulation laid by the EGoM.

Deepak Fert stock price

On May 15, 2014, Deepak Fertilizers and Petrochemicals Coprn closed at Rs 141.50, up Rs 5.95, or 4.39 percent. The 52-week high of the share was Rs 149.00 and the 52-week low was Rs 81.20.


The company's trailing 12-month (TTM) EPS was at Rs 20.58 per share as per the quarter ended December 2013. The stock's price-to-earnings (P/E) ratio was 6.88. The latest book value of the company is Rs 149.00 per share. At current value, the price-to-book value of the company is 0.95.


08.11 | 0 komentar | Read More

Deal street bullish on prospect of new govt: Raja Lahiri

The mergers and acquisitions activity in the new fiscal has been good, with USD 6.8 billion of M&A activity alone, says Raja Lahiri, Partner, Grant Thorton. According to him, the deal makers are bullish on the new government and there is clearly a surge in the momentum within dealers.

However, he believes, it will take a while to trigger off the momentum into significant deals but as the new government settles down the reforms are clearly articulated. He is bullish on infra, retail, consumer, pharma going ahead.

Below are excerpts of the interview:

Q: It seems like good news, there is a definite pickup in April compared to the action seen before, according to your report?

A: April 2014 has started with a bang. Nearly, USD 7.5 billion of M&A and private equity is probably the biggest number in the last three years and that's very good news. Out of that USD 6.8 billion is M&A. We have seen USD 2 billion transactions this month and private equity has been steady as well. So, the New Year has started with a very good momentum.

Q: Several big ticket deals and rise in price earning (PE) investments took place in April. Which major deal caught your attention? Even sectorally, which sectors were in focus?

A: The biggest deal of this month was Sun Pharmaceutical –  Ranbaxy deal of USD 3 plus billion, clearly a landmark deal which makes Sun Pharma the fifth largest generic player globally.

The second one was the Vodafone deal which was the exit of Piramal Enterprises that made an investment of more than USD 1 billion with a fantastic exit return for Piramals. As far as private equity is concerned, we saw continued investments in e-commerce sector, smaller deals though. We saw deals across sectors like Ratnakar Bank raising money from CDC group and Mercator raising money from Aion Capital. So, private equity has been there pretty much across sectors.

Q: We are on the eve of counting day tomorrow and it is verdict day and we are likely to have a new government by this time tomorrow. What is the outlook given the change in circumstances for Deal Street. Do we expect a further pickup in M&A activity?

A: Deal makers are absolutely bullish. There is clearly a surge in momentum within the deal maker community. The wait and watch mode is hopefully going to changeover to a positive outlook going forward. The only word of caution would be that it is not going to just trigger off into a significant deal momentum immediately but as the new government settles down the reforms are clearly articulated, definitely we see action across some key sectors – infra, retail, consumer, pharma, top sectors which could see fair bit of action. So, absolutely positive outlook once the new government comes in.


08.11 | 0 komentar | Read More

New gas rates to be applicable from Apr 1: RIL to buyers

Written By Unknown on Kamis, 15 Mei 2014 | 08.11

In a terse one-page letter to urea manufacturing plants, RIL said it was supplying about 12.5 million standard cubic meters per day of gas since April 1 at provisional price of USD 4.205 per mmBtu, and will charge them the difference between this and the new rate as and when it is approved by the government.

Forced to sell gas at rates that have long expired,  Reliance Industries has categorically told buyers of its KG-D6 gas that new rates as and when approved, will apply from April 1.

In a terse one-page letter to urea manufacturing plants, RIL said it was supplying about 12.5 million standard cubic meters per day of gas since April 1 at provisional price of USD 4.205 per million British thermal unit, and will charge them the difference between this and the new rate as and when it is approved by the government.

Also Read: Gas price revision delay may stall $4 bn investment: RIL

The government had in 2007 fixed a price of USD 4.205 per mmBtu for gas from KG-D6 block in Bay of Bengal for first five years of production. Dhirubhai-1 and 3 and MA fields in the KG-D6 began production in April 2009 and the rate approved expired on March 31, 2014.

The Cabinet had last year approved a new formula for pricing of all domestically produced gas from April 1. The formula was notified on January 1 and published in Gazette of India on January 17 but before a new rate based on 12-month average price prevailing in international hubs and actual cost of importing LNG into the country, could be announced general elections were declared.

The Election Commission asked the government to defer announcement of the new price till completion of the polls and so RIL was asked to continue selling the gas at old rates. Price according to the new formula is likely to be USD 8.3 mmBtu.

While several customers in sectors like power have accepted the terms of gas supply from KG-D6 from April 1 and have already executed Term Sheet, fertilizer sector buyers have refused to sign even as they continue to take gas without a contract.

"We would additionally like to inform you that we have initiated arbitration process against the Government of India in relation to Government's continued delay in notifying the gas price applicable under the Domestic Natural Gas Pricing Guidelines, 2014," RIL wrote on Tuesday.

RIL told the fertiliser firms that their acceptance or receiving of KG-D6 gas meant that they acknowledge and accept that the gas price formula leading to a gas price of USD 4.205 per mmBtu has expired on March 31, 2014 and new rates will apply from April 1.

"The gas price payable for the supplies received by you from April 1, 2014 onwards shall be the price as may be made applicable from such date by virtue of a notification by the government or the outcome of the arbitration," it wrote.

RIL and its partners BP Plc of UK and Canada's Niko Resources had on Friday slapped an arbitration notice on the government over delay in implementation of the new rates.

"You (fertilizer firms) have the option of not accepting the gas, but please note that by continuing to accept the gas being supplied to you, you will be deemed to have accepted the above conditions," it added.

Reliance stock price

On May 14, 2014, Reliance Industries closed at Rs 1045.55, down Rs 15.8, or 1.49 percent. The 52-week high of the share was Rs 1067.00 and the 52-week low was Rs 765.00.


The company's trailing 12-month (TTM) EPS was at Rs 68.01 per share as per the quarter ended March 2014. The stock's price-to-earnings (P/E) ratio was 15.37. The latest book value of the company is Rs 556.88 per share. At current value, the price-to-book value of the company is 1.88.


08.11 | 0 komentar | Read More

Bajaj Auto union postpones strike plans

Earlier on April 14, the union had issued a notice to Baja Auto's management, threatening an indefinite strike at the Chakan plant in Pune from April 27, if its demands were not met.

Bajaj Auto employees' union has postponed its proposed strike from tomorrow after considering suggestions of Shramik Ekta Mahasangh, the umbrella organisation of trade unions in the region. It, however, added that if Mahasangh's intervention also fails it will will have no option but go ahead with plans of agitation.

The union's list of demands include allocation of allotment of shares at a discounted price, corporate social responsibility (CSR) funds for education of employees' children, setting up a museum in the name of the company's founder Jamnalal Bajaj within a year. Earlier on April 14, the union had issued a notice to the Baja Auto's management, threatening an indefinite strike at the Chakan plant in Pune from April 27, if its demands were not met.

Also Read: Strength seen in 2-wheeler sales to continue, says SIAM

Later, the Bajaj Auto employees' union, Vishwa Kalyan Kamgar Sanghatna (VKSS) had deferred the proposed agitation to May 15 after deciding to grant two weeks time to the company management to look into its demands. "We had a meeting with the Shramik Ekta Mahasangh, the umbrella organisation of trade unions in the region, on April 14 and April 28, which had said that it would look into the matter. Considering their suggestions, we decided to postpone our stoppage of work plan. "However, if the matter does not get resolved even after the Mahasangh's intervention, the union will not have any other option, but continue with its decision (stoppage of work)," VKKS said in a letter to the management today.

Stating that it would announce a fresh date of agitation at a later stage, the union expressed hope that an amicable solution would be found with the help of the Mahasangh's intervention. The Chakan plant employs more than 2,000 workers, including around 900 permanent ones, and produces 1.2 million bikes including the Pulsar, Avenger, Ninja and KTM brands per year.

However, the Bajaj auto management had termed the union's demands as "insane" and said it would ensure that production at the Chakan plant is not hit, if the union made any attempt to disrupt the same.

Bajaj Auto stock price

On May 14, 2014, Bajaj Auto closed at Rs 2040.55, up Rs 61.35, or 3.10 percent. The 52-week high of the share was Rs 2193.85 and the 52-week low was Rs 1683.35.


The company's trailing 12-month (TTM) EPS was at Rs 112.15 per share as per the quarter ended December 2013. The stock's price-to-earnings (P/E) ratio was 18.19. The latest book value of the company is Rs 273.08 per share. At current value, the price-to-book value of the company is 7.47.


08.11 | 0 komentar | Read More

Coal India modifies performance incentive clause in FSA

Written By Unknown on Rabu, 14 Mei 2014 | 08.11

In the meeting held in early this year "it was deliberated that some clarity shall be brought in the provision for computation of performance incentive clause in case of now power model FSAs to clarify that such PI is applicable only on actual delivered quantity of coal," the letter said.

State-owned  Coal India (CIL) has tweaked the performance incentive clause in fuel supply agreements with non-power consumers. Under the performance incentive clause, if the seller (Coal India) issues sale orders for coal to the purchaser in excess of 90 percent of the assured contracted quantity in a particular year, the purchaser shall pay the seller an incentive.

Under the revised clause, performance incentive is applicable only on actual delivered quantity of coal. "The relevant provision of the performance incentive clause of non-power FSA models has been modified to impart the required clarity," Coal India said in a letter to its subsidiaries.

In the meeting held in early this year "it was deliberated that some clarity shall be brought in the provision for computation of performance incentive clause in case of now power model FSAs to clarify that such PI is applicable only on actual delivered quantity of coal," the letter said.

Amid continuous delays, the maharatna PSU has so far signed 160 fuel supply pacts with power units. The Cabinet Committee on Investment (CCI) had earlier stated that the time lines for signing of fuel supply pacts for power projects of 78,000 MW capacity should be met.

CIL has to sign 172 FSAs for a capacity of 78,000 MW. Two deadlines set for the signing of FSAs by CIL with the power producers could not be adhered to. The Coal Ministry had set the deadline of August 31, 2013 for signing of the FSAs, which could not be met.

Also Read: Coal India's April production at 37.5 MT

Coal India stock price

On May 13, 2014, Coal India closed at Rs 331.65, up Rs 0.85, or 0.26 percent. The 52-week high of the share was Rs 342.35 and the 52-week low was Rs 238.35.


The company's trailing 12-month (TTM) EPS was at Rs 26.41 per share as per the quarter ended December 2013. The stock's price-to-earnings (P/E) ratio was 12.56. The latest book value of the company is Rs 32.48 per share. At current value, the price-to-book value of the company is 10.21.


08.11 | 0 komentar | Read More

GSM players add 49.7 lakh users in April: COAI

Country's largest telecom operator Bharti Airtel added the maximum users during the month with 11.92 lakh subscribers joining its network. The company's total user base stood at 20.65 crore at the end of April with 28.42 percent market share.

The GSM subscriber base in the country grew marginally in April to 72.69 crore with telecom operators adding 49.7 lakh new users in the month, industry body COAI said today.

The GSM user base stood at 72.19 crore at the end of March, Cellular Operators Association of India (COAI) said. Country's largest telecom operator  Bharti Airtel added the maximum users during the month with 11.92 lakh subscribers joining its network. The company's total user base stood at 20.65 crore at the end of April with 28.42 percent market share.

Vodafone added 7.31 lakh users during the month to take its overall base to 16.72 crore and market share of 23.01 percent whereas Idea Cellular added 7.70 lakh subscribers and its user base at the end of April stood at 13.65 crore.

Aircel added 9.98 lakh users and Uninor added 9.68 lakh new subscribers in April. The respective user bases stood at 7.11 crore and 3.65 crore. Videocon also added 2.95 lakh users to take its subscriber base to 52.82 lakh at the end of April. State-run  MTNL added 12,794 new subscribers to increase its base to 32.57 lakh during the reported period. BSNL did not report its subscriber figures.

Bharti Airtel stock price

On May 13, 2014, Bharti Airtel closed at Rs 319.90, up Rs 2.15, or 0.68 percent. The 52-week high of the share was Rs 373.50 and the 52-week low was Rs 274.50.


The company's trailing 12-month (TTM) EPS was at Rs 16.51 per share as per the quarter ended March 2014. The stock's price-to-earnings (P/E) ratio was 19.38. The latest book value of the company is Rs 152.21 per share. At current value, the price-to-book value of the company is 2.10.


08.11 | 0 komentar | Read More

Diesel price hiked by Rs 1.09 a litre after polling ends

Written By Unknown on Selasa, 13 Mei 2014 | 08.11

After a brief hiatus, diesel prices were Monday hiked by Rs 1.09 a litre, excluding state levies.

The monthly increases in diesel rates, which had been put on hold just before India began voting to elect a new government, were back no sooner than polling ended today.

The hikes, effective from midnight tonight, are excluding state sales tax or VAT and actual increase will be higher and will vary from city to city, the oil companies announced.

Also Read: Euro-IV petrol, diesel in 50 more cities by March 2015

Diesel price in Delhi will be hiked by Rs 1.22 a litre after including taxes, to Rs 56.71 per litre, while it will cost Rs 65.21 a litre in Mumbai as against Rs 63.86 at present.

State-owned oil companies, which had last hiked diesel price on March 1, will lose Rs 5.71 a litre even after today's hike.

The Cabinet had in January last year decided that diesel prices should be raised by 40-50 paise a litre every month until losses on the fuel are wiped out. However, oil firms skipped the hikes due on April 1 and May 1 as UPA did not want to take unpopular decision during election season.

The deferred hikes have now been implemented. Before today's increase, diesel prices had risen by a cumulative Rs 8.33 a litre in 14 instalments since January 2013.

There will be no change in petrol rates even though the oil firms were losing about 50 paise a litre due to depreciation in value of rupee against the US dollar.

Oil PSUs IOC ,  BPCL and  HPCL had on April 1 skipped raising diesel rates as per the January 2013 decision of the Cabinet of small monthly raises, on the plea that revenue losses on the fuel have dropped below Rs 6 a litre.

They again did not raise rates on May 1 even though the losses had climbed to Rs 6.80 per litre.

The oil ministry had at the time of shelving the April hike stated that an expert committee headed by Kirit Parikh recommended that government provide a fixed subsidy of Rs 6 per litre on diesel and so there was no need to raise rates if the revenue losses were below this threshold.

While the government is yet to accept the Parikh panel recommendations, the Oil Ministry, wary of the political fallout due to the unpopular move to raise prices, approached the poll watchdog towards March-end seeking its nod to keep monthly raises in abeyance.

The Election Commission did not respond to the Ministry's request for over a month, a development that was cited to yet again for not raising fuel rates on May 1 even though losses had surpassed the Rs 6 a litre threshold.

The Election Commission has now told the Ministry that since the revenue loss on the fuel is currently Rs 6.80 per litre, it is for the Oil Ministry to take a decision on raising rates.

"As a sequel to the under-recovery on diesel having fallen below Rs 6 per litre, Ministry of Petroleum and Natural Gas had referred the matter to Election Commission of India on
March 31, 2014. Accordingly, PSU oil marketing companies did not increase prices of diesel on April 1, 2014 and May 1, 2014.

"As the proposed change has not been accepted by the Election Commission, the oil marketing companies are required to effect both the price increases together," said Indian Oil Corp, the nation's largest fuel retailer.

IOC said even after today's increase, oil firms will have an under-recovery (revenue loss) of Rs 5.71 a litre on diesel. Diesel rates had risen regularly barring just one time.

Oil companies skipped raising diesel prices in April 2013, when assembly elections were held in Oil Minister M Veerappa Moily's home state Karnataka. However, they made up by hiking diesel prices by 90 paise in the following month.


08.11 | 0 komentar | Read More

Voda: FinMin moves Cabinet for withdrawing from peace talks

Vodafone in a letter to the Revenue Department dated March 13 had stated they saw no merit in reviewing the matter of conciliation in the Rs 20,000-crore capital gains tax dispute case after receipt of the decision of the ITAT.

The Finance Ministry today said it has moved the Cabinet for withdrawing from conciliation proceedings to resolve the tax row with Vodafone after the UK-based telecom firm served notice of arbitration.

Vodafone in a letter to the Revenue Department dated March 13 had stated they saw no merit in reviewing the matter of conciliation in the Rs 20,000-crore capital gains tax dispute case after receipt of the decision of the ITAT.

Also Read: DoT ready for final allocation of airwaves

It had further said that the only body capable of resolving the issue would be an arbitration panel constituted according to the Bilateral Investment Promotion and Protection Agreement (BIPA). Listing out the sequence of events, the Finance Ministry in a statement said it was then decided to approach the Cabinet again, bringing these facts to it notice and seeking approval for withdrawing from conciliation.

"Meanwhile, without waiting for the outcome of the ITAT proceedings, Vodafone International Holdings BV (VIHBV) has served a 'Notice of Arbitration' dated April 17 seeking arbitration under the BIPA between India and the Netherlands," the official statement said.

Earlier in February, the Cabinet had deferred considering the proposal to withdraw from conciliation talks with the UK-based firm, pending settlement of Rs 3,700 crore Vodafone's transfer-pricing case at the Income Tax Appellate Tribunal (ITAT).

Last year in June, the Cabinet had approved conciliation with Vodafone to resolve the capital gains tax dispute related to its 2007 acquisition of Hutchison Whampoa's stake in Hutchison Essar. While the basic tax demand is Rs 7,990 crore, the total outstanding is Rs 20,000 crore after including penalty.

The Supreme Court had ruled in Vodafone's favour in 2012, saying it was not liable to pay any tax over the acquisition of assets in India from Hong Kong-based Hutchison. The government changed the rules later in 2012 to enable it to claim tax retrospectively on concluded deals.


08.11 | 0 komentar | Read More

IFCI plans to sell stake in factoring subsidiary

Written By Unknown on Senin, 12 Mei 2014 | 08.11

State-run IFCI expects to complete part-selling of its stake in IFCI Factors Ltd, its factoring business subsidiary, by the end of this fiscal.

State-run  IFCI expects to complete part-selling of its stake in IFCI Factors Ltd, its factoring business subsidiary, by the end of this fiscal.

"We plan to sell a part of our stake in factoring business. We have started the process of due diligence.

Hopefully, it should be complete by March 2015," IFCI Managing Director Malay Mukherjee told PTI.

The company plans to sell 25-26 percent stake so that the majority stake remains with IFCI, he said, adding the strategic sale would help IFCI unlock its investment.

Currently, the company holds 100 percent stake in IFCI Factors Ltd.

Factoring business is a type of financial service wherein a firm sells its accounts receivable to a factoring company, which then pay discounted value to seller against receivable receipts.

Earlier in 2011, IFCI Factors had filed draft prospectus with Securities and Exchange Board of India (Sebi) for an initial public offer for raising Rs 750-1,000 crore from public. It, however, shelved the plan later due to bad market conditions.

Besides, IFCI has also decided to partially sell its stake in NSE. The infrastructure lender at present holds 5.44 percent stake in the premier bourse.

The board has given in-principle approval for sale of 2.5 percent stake in NSE, he said.

The country's oldest financial institution initially held 12.44 percent stake in the Mumbai-based NSE, but sold 7 percent to Goldman Sachs Group Inc, NYSE Group Inc, General Atlantic LLC and Softbank Asian Infrastructure Fund in 2007.

In December 2012, the financial institution had become a state-owned entity with government getting 55.53 percent stake by conversion of optionally convertible bonds.

IFCI recently acquired additional 18.98 percent stake in Stock Holding Corporation of India (SHCIL) from IDBI Bank for an undisclosed amount.

Also Read: IFCI seeks govt nod to raise Rs 1,000 cr via tax-free bonds

Following acquisition, IFCI became majority owner with 52.86 percent in SHIL.

IFCI stock price

On May 09, 2014, IFCI closed at Rs 26.70, up Rs 1.55, or 6.16 percent. The 52-week high of the share was Rs 31.45 and the 52-week low was Rs 17.85.


The company's trailing 12-month (TTM) EPS was at Rs 3.06 per share as per the quarter ended March 2014. The stock's price-to-earnings (P/E) ratio was 8.73. The latest book value of the company is Rs 41.68 per share. At current value, the price-to-book value of the company is 0.64.


08.11 | 0 komentar | Read More

FIPB to take up 34 FDI proposals on Tuesday

The Foreign Investment Promotion Board (FIPB) will take up 34 FDI proposals, including that of Ranbaxy Laboratories, Sistema Shyam and AT&T Global, on Tuesday.

The Foreign Investment Promotion Board (FIPB) will take up 34 FDI proposals, including that of Ranbaxy Laboratories , Sistema Shyam and AT&T Global, on Tuesday.

The other proposals which are before the board include those of Indian Rotocraft, Tech Mahindra , Bharti Shipyard and Johnson and Johnson Ltd.

The FIPB, chaired by Economic Affairs Secretary Arvind Mayaram, would meet on May 13 to decide on the proposals, sources said.

Of the proposals before the FIPB, Sistema Shyam Teleservices has sought the government approval to raise foreign stake in the firm beyond the current 74 percent.

Russian conglomerate Sistema JSFC holds 56.68 percent in SSTL, Russian government 17.14 percent and 0.13 percent other foreign entities.

SSTL is the second operator after Vodafone that has approached FIPB for raising FDI limit.

Besides, American telecom firm AT&T Global Network, which provides internet bandwidth and related services to business houses, has approached FIPB to raise its stake in Indian arm.

AT&T hold international and national long distance (ILD/NLD) telecom services licences in partnership with Mahindra Telecommunications.

Sources said that AT&T has plans to go solo in India as government has increased FDI cap in telecom sector to 100 percent.

"Foreign ILD and NLD operators would be interested in raising their stake as joint ventures with Indian partners were mere regulatory formality," sources said.

Although it could not be immediately ascertained the proposal of Ranbaxy Laboratories, it may be recalled that last month Sun Pharma had announced to acquire Ranbaxy in an all stock transaction with a total equity value of USD 3.2 billion, along with debt of USD 800 million taking the overall deal value to USD 4 billion.

Also Read: CCEA likely to take up KKR's proposal today

Currently, Daiichi owns around 63.41 percent of the shares of Ranbaxy. The company is scheduled to acquire about 9 percent stake in Sun Pharma as a result of the merger.

Ranbaxy Labs stock price

On May 09, 2014, रेनबैक्सी लेबोरेटरीज closed at Rs 463.60, down Rs 5.9, or 1.26 percent. The 52-week high of the share was Rs 505.00 and the 52-week low was Rs 253.95.


The latest book value of the company is Rs 3.41 per share. At current value, the price-to-book value of the company was 135.95.


08.11 | 0 komentar | Read More

RIL serves arbitration notice to govt on gas pricing issue

Written By Unknown on Minggu, 11 Mei 2014 | 08.11

Reliance is currently selling gas at USD 4.2/mmbtu; the Cabinet's decision to allow a higher gas price had to be deferred because of the Election Commission's model code of conduct.

Moneycontrol Bureau

Reliance Industries , along with BP and Niko, have sent an arbitration notice to the government seeking higher gas prices under the 'Domestic Natural Gas Pricing Guideline 2014' notified in January this year.

Reliance is currently selling gas at USD 4.2/mmbtu; the Cabinet's decision to allow doubling of gas price had to be deferred because of the Election Commission's model code of conduct.

"The continuing delay on part of the Government of India in notifying the price in accordance with the approved formula for the gas to be sold has left the Parties with no other option but to pursue this course of action," said the Reliance Industries press release.

(RIL's arbitration notice to govt: Experts analyse implications)

"Without this clarity, the Parties are unable to sanction planned investments of close to $4 billion this year. In addition, this will also delay the ability of the Parties to appraise and develop other significant discoveries made last year," the released.

In an interview to CNBC-TV18, Reliance's lawyer Harish Salve said that his client had to protect its commercial interests and could not wait till the next government took charge.

"God knows when the government will be formed, who the government will be, what they will do, they will take their own time," he said. 

He said he was hopeful that the government would agree to a middle-ground solution.

The current government has barely 10 more days of office.

Salve said his client was forced to take this extreme step since repeated letters to the government has not yielded any results. He said the company was now in a litigation mode after having exhausted all means for an amicable settlement. There would be no more talks with the government, and the ball was now in the government's court, said Salve.

He said he was meeting RIL representatives next week to decide on the next step.

Salve refused to comment on what price RIL would supply gas to user industries from Monday.

Next page: Transcript of Harish Salve's interview on CNBC-TV18

Reliance stock price

On May 09, 2014, Reliance Industries closed at Rs 997.35, up Rs 37.70, or 3.93 percent. The 52-week high of the share was Rs 999.00 and the 52-week low was Rs 765.00.


The company's trailing 12-month (TTM) EPS was at Rs 68.01 per share as per the quarter ended March 2014. The stock's price-to-earnings (P/E) ratio was 14.66. The latest book value of the company is Rs 556.88 per share. At current value, the price-to-book value of the company is 1.79.


08.11 | 0 komentar | Read More
techieblogger.com Techie Blogger Techie Blogger